A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, April 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

facebook: 1 Facebook page

Citations

dimensions_citation: 117 Dimensions

Readers on

mendeley: 91 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 X post from an account with 11,414 followers.

《短報》【膵がん：一次治療】「mFOLFIRINOX」治療を選択した場合の奏効率37.7%、病勢コントロール率78.3％、無増悪生存期間5.5ヵ月、生存期間11.2ヵ月。日本のPhase 2試験結果より。〔Cancer Chemother Pharmacol〕 https://t.co/lAp5Ij7ijp

12 Apr 2018

Reply Repost Favourite